Corporate calendar for TransCode Therapeutics, Inc. (RNAZ): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
TransCode Therapeutics, Inc. is a biopharmaceutical firm dedicated to pioneering and marketing therapeutic agents and diagnostic tools specifically aimed at combating and detecting metastatic disease. Central to its pipeline is TTX-MC138, a lead therapeutic compound currently undergoing preclinical evaluation for its potential in treating advanced, spreading cancers.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-15 | ||
| 2026-09-15 | ||
| 2026-09-15 | $0.04 | $67M |
| 2026-09-15 | ||
| 2026-09-15 | $344M | |
| 2026-09-15 |
Stock Splits
| Date | Ratio |
|---|---|
| 2025-05-15 | 1:28 |
| 2024-12-04 | 1:33 |
| 2024-01-16 | 1:40 |
| 2023-05-23 | 1:20 |
Price
| Price | $1.68 |
| Market Cap | $2M |
| Exchange | NASDAQ |
| Country | US |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 1 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 1 |
| Avg rating (1-5) | 1.00 |
Related companies: ACXP · APRE · APVO · BOLT · GLTO · HCWB · INAB
Explore sector: Healthcare · Biotechnology
More sections of RNAZ: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks